Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats - PubMed (original) (raw)

Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats

J R Bethea et al. J Neurotrauma. 1999 Oct.

Abstract

In these studies, we examined the neuroprotective effects of the potent antiinflammatory cytokine interleukin-10 (IL-10) following spinal cord injury (SCI). Neuroprotection was assessed by using behavioral and morphological end points. We hypothesized that injury-induced inflammation contributes to the resulting neuropathology and subsequent loss of function. Therefore, by attenuating injury-induced inflammation, we should promote functional recovery. The New York University device was used to induce moderate SCI and study the resulting inflammatory response and functional consequences of inhibiting this response in rats. We determined that SCI induces the expression of tumor necrosis factor-alpha (TNF-alpha) in the spinal cord and by SCI-activated monocytes isolated from the peripheral circulation. IL-10 (5.0 microg) administered 30 minutes after-injury significantly reduced the expression of TNF-alpha protein in the spinal cord and in vitro by SCI-activated monocytes. Next, we investigated whether IL-10 would improve functional recovery after SCI. Randomized, double-blinded studies demonstrated that a single injection of IL-10 significantly improves hind limb motor function 2 months after injury, as determined by the Basso, Beattie and Bresnahan (BBB) open-field behavioral test. IL-10-treated animals had a mean BBB score of 18.0+/-0.5 (SEM, n = 9) compared with a score of 12.9+/-0.6 (SEM, n = 9) for the saline-treated controls. Morphological analysis demonstrated that IL-10 reduces lesion volume by approximately 49% 2 months after injury. These data suggest that acute administration of IL-10 reduces TNF-alpha synthesis in the spinal cord and by activated macrophages, is neuroprotective, and promotes functional recovery following SCI.

PubMed Disclaimer

Cited by

PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype.
Wada Y, Nakamachi T, Endo K, Seki T, Ohtaki H, Tsuchikawa D, Hori M, Tsuchida M, Yoshikawa A, Matkovits A, Kagami N, Imai N, Fujisaka S, Usui I, Tobe K, Koide R, Takahashi H, Shioda S. Wada Y, et al. J Mol Neurosci. 2013 Oct;51(2):493-502. doi: 10.1007/s12031-013-0017-5. Epub 2013 May 30. J Mol Neurosci. 2013. PMID: 23720065
Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.
Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, Steeves JD, Ramer MS, Tetzlaff W. Stirling DP, et al. J Neurosci. 2004 Mar 3;24(9):2182-90. doi: 10.1523/JNEUROSCI.5275-03.2004. J Neurosci. 2004. PMID: 14999069 Free PMC article.
Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice.
Hendricks WA, Pak ES, Owensby JP, Menta KJ, Glazova M, Moretto J, Hollis S, Brewer KL, Murashov AK. Hendricks WA, et al. Mol Med. 2006 Jan-Mar;12(1-3):34-46. doi: 10.2119/2006-00014.Hendricks. Mol Med. 2006. PMID: 16838066 Free PMC article.
Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
Parviainen L, Dihanich S, Anderson GW, Wong AM, Brooks HR, Abeti R, Rezaie P, Lalli G, Pope S, Heales SJ, Mitchison HM, Williams BP, Cooper JD. Parviainen L, et al. Acta Neuropathol Commun. 2017 Oct 17;5(1):74. doi: 10.1186/s40478-017-0476-y. Acta Neuropathol Commun. 2017. PMID: 29041969 Free PMC article.
Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity.
Byrnes KR, Stoica B, Loane DJ, Riccio A, Davis MI, Faden AI. Byrnes KR, et al. Glia. 2009 Apr 1;57(5):550-60. doi: 10.1002/glia.20783. Glia. 2009. PMID: 18816644 Free PMC article.

Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats - PubMed (original) (raw)